MicroTransponder secures US$65 Million Financing Round to Boost Adoption of Vivistim Stroke Therapy

The views and opinions of the media, healthcare professionals, patients and caregivers may not be accurately represented based on the Vivistim System’s FDA approved indication. For more information, please visit www.vivistim.com/safety.